Korde N - Search Results

1

Proteomic profiling in plasma cell disorders: a feasibility study.

Mailankody S, Devlin SM, Korde N, Lendvai N, Lesokhin A, Landau H, Hassoun H, Ballagi A, Ekman D, Chung DJ, Patel M, Koehne G, Giralt S, Landgren O. Mailankody S, et al. Among authors: korde n. Leuk Lymphoma. 2017 Jul;58(7):1757-1759. doi: 10.1080/10428194.2016.1258699. Epub 2016 Dec 2. Leuk Lymphoma. 2017. PMID: 27908223 Free PMC article. No abstract available.

2

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.

Korde N, Kristinsson SY, Landgren O. Korde N, et al. Blood. 2011 May 26;117(21):5573-81. doi: 10.1182/blood-2011-01-270140. Epub 2011 Mar 25. Blood. 2011. PMID: 21441462 Free PMC article. Review.

3

Current and future imaging modalities for multiple myeloma and its precursor states.

Tan E, Weiss BM, Mena E, Korde N, Choyke PL, Landgren O. Tan E, et al. Among authors: korde n. Leuk Lymphoma. 2011 Sep;52(9):1630-40. doi: 10.3109/10428194.2011.573036. Epub 2011 Jun 8. Leuk Lymphoma. 2011. PMID: 21649546 Free PMC article. Review.

4

Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management.

Kristinsson SY, Minter AR, Korde N, Tan E, Landgren O. Kristinsson SY, et al. Among authors: korde n. Expert Rev Mol Diagn. 2011 Jul;11(6):593-603. doi: 10.1586/erm.11.44. Expert Rev Mol Diagn. 2011. PMID: 21745013 Free PMC article. Review.

5

Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).

Mailankody S, Pfeiffer RM, Kristinsson SY, Korde N, Bjorkholm M, Goldin LR, Turesson I, Landgren O. Mailankody S, et al. Among authors: korde n. Blood. 2011 Oct 13;118(15):4086-92. doi: 10.1182/blood-2011-05-355743. Epub 2011 Jul 27. Blood. 2011. PMID: 21795746 Free PMC article. Clinical Trial.

6

Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities.

Landgren O, Korde N. Landgren O, et al. Among authors: korde n. Oncology (Williston Park). 2011 Jun;25(7):589-90. Oncology (Williston Park). 2011. PMID: 21888256 Free article. Review. No abstract available.

7

Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma.

Landgren O, Ma W, Kyle RA, Rajkumar SV, Korde N, Albitar M. Landgren O, et al. Among authors: korde n. Leukemia. 2012 Apr;26(4):844-5. doi: 10.1038/leu.2011.262. Epub 2011 Sep 16. Leukemia. 2012. PMID: 21926963 Free PMC article. No abstract available.

8

Antigenic drift in relapsed extramedullary multiple myeloma: plasma cells without CD38 expression.

Tembhare P, Yuan C, Korde N, Maric I, Landgren O. Tembhare P, et al. Among authors: korde n. Leuk Lymphoma. 2012 Apr;53(4):721-4. doi: 10.3109/10428194.2011.623257. Epub 2011 Nov 25. Leuk Lymphoma. 2012. PMID: 21942285 Free PMC article. No abstract available.

9

Second malignancies after multiple myeloma: from 1960s to 2010s.

Thomas A, Mailankody S, Korde N, Kristinsson SY, Turesson I, Landgren O. Thomas A, et al. Among authors: korde n. Blood. 2012 Mar 22;119(12):2731-7. doi: 10.1182/blood-2011-12-381426. Epub 2012 Feb 6. Blood. 2012. PMID: 22310913 Free PMC article. Review.

10

Bortezomib to treat the TEMPI syndrome.

Kwok M, Korde N, Landgren O. Kwok M, et al. Among authors: korde n. N Engl J Med. 2012 May 10;366(19):1843-5. doi: 10.1056/NEJMc1202649. N Engl J Med. 2012. PMID: 22571216 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters